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Studies on the pathogenesis of diabetes mellitus complications indicate that the compounds reducing free radicals and 
enhancing DNA repair could be prospective as possible remedies. Carbatonides, the disodium-2,6-dimethyl-1,4-
dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives, were tested for these properties. EPR spectroscopy showed that 
metcarbatone was an effective scavenger of hydroxyl radicals produced in the Fenton reaction, etcarbatone, and 
propcarbatone were less effective, styrylcarbatone was ineffective. UV/VIS spectroscopy revealed that styrylcarbatone 
manifested a hyperchromic effect when interacting with DNA, while all other carbatonides showeda hypochromic effect. 
Rats with streptozotocin induced type 1 DM were treated with metcarbatone, etcarbatone or styrylcarbatone (all compounds 
at doses 0.05 mg kg-1 or 0.5 mg kg-1) nine days after the DM approval. Gene expression levels in kidneys and blood were 
evaluated by quantitative RT-PCR; protein expression - immunohistochemically in kidneys, heart, sciatic nerve, and eyes; 
DNA breakage - by comet assay in nucleated blood cells. Induction of DM induced DNA breaks; metcarbatone and 
styrylcarbatone (low dose) alleviated this effect. Metcarbatone and etcarbatone up-regulated mRNA and protein of eNOS 
in kidneys of diabetic animals; etcarbatone also in myocardium. Etcarbatone reduced the expression of increased iNOS 
protein in myocardium, nerve, and kidneys. iNos gene expression was up-regulated in kidneys by etcarbatone and 
metcarbatone in diabetic animals. In blood, development of DM increased iNos gene expression; etcarbatone and 
metcarbatone normalised it. Etcarbatone up-regulated the expression of H2AX in kidneys of diabetic animals but decreased 
the production of c-PARP1. Taken together, our data indicate that carbatonides might have a potential as drugs intended 
to treat DM complications.
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New remedies for treatment of type one diabetes 
mellitus (T1DM) complications are sought among 
compounds with antioxidant activities (1, 2). Following this 
logic, we have chosen some representatives of group of 
1,4-dihydropyridine (1,4-DHP) derivatives synthesised in 
the Latvian Institute of Organic Synthesis (see Table 1 for 
structures). These compounds did not manifest high Ca2+-
channel blocker activity (3), however, they displayed 
antioxidant activities (4) and interfered with mitochondria 
by uncoupling respiration and phosphorylation (5). Some 
of these compounds manifested antidiabetic activities. For 
example, cerebrocrast promoted decrease of food intake 
(6), protected pancreatic cells from streptozotocin (STZ)-
induced damage and reduced glucose level in blood of 
animals with developed DM (7, 8), and acted synergistically 
with insulin on heart functions and metabolism in diabetic 
rats (9). The same 1,4-DHP derivative and its analogues 
normalised nitric oxide (NO) production in diabetic animals 
and modified expression of genes involved in NO 
metabolism (10). Besides its antioxidant properties, 1,4-
DHP derivative AV-153 turns out to be a DNA repair 
enhancer (11) capable of interacting directly with DNA 
(12); cerebrocrast and its analogues manifest identical 
properties (10). We have shown that AV-153 down-regulates 
poly(ADP)ribose polymerase 1 (PARP1) and inducible NO 
synthase (iNOS) protein expression and increases the level 
of endothelial NO synthase (eNOS) protein and H2A histone 
family member X (H2afx) gene expression in kidneys of 
animals with experimental DM (13). Several 1,4-DHPs 
modify expression of proteasomal genes (14). Taken 
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together, this group of 1,4-DHP derivatives appeared to be 
prospective for the study of their possible application as 
remedies against DM complications and should be studied 
further.
The aim of the present work was to test disodium-2,6-
dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) 
derivatives (carbatonides) with different groups in position 
4 by means of EPR spectroscopy for its capability to 
scavenge hydroxyl radical produced in the Fenton reaction, 
to protect DNA against above mentioned radicals in vitro, 
and to bind DNA. A series of in vivo experiments were 
conducted to study mRNA and protein expression levels in 
healthy animals and the expression of several proteins and 
genes involved in apoptosis, DNA repair, and free radical 
production in animals with STZ-induced diabetes mellitus. 
It is considered that impaired production of NO is a crucial 
point in development of DM complications. It is mainly 
due to the uncoupling of eNOS and overexpression of iNOS, 
as well as increased NO synthase-independent generation 
of NO by xanthine dehydrogenase (XDH) (10, 13 and 
references therein). This determined the choice of the 
abovementioned genes. Generation of DNA lesions and 
impaired DNA repair is also an important step in the 
pathogenesis of DM complications. The level of poly(ADP)
ribose synthesis by PARPs characterises the intensity of the 
repair response to DNA lesions. This determined the choice 
of the PARP1 gene and protein study; moreover, the cleaved 
form of the protein is a sensitive apoptosis marker. H2AX 
histone, a sensitive marker of DNA double strand breaks, 
was chosen also to characterise the level of DNA lesions 
(13 and references therein).
MATERIALS AND METHODS
Chemicals 
Carbatone, metcarbatone, etcarbatone, propcarbatone, 
and styrylcarbatone (J-9-125) (Table 1) were synthesised 
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Table 1 Chemical structures of carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives]
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at the Latvian Institute of Organic Synthesis and 
characterised by usual physico-chemical methods: 
1H-NMR, 13C-NMR, IR spectroscopy, as well as LC-MS 
and elemental analysis. STZ, citric acid, EDTA, ferrous 
sulphate, hydrogen peroxide, low-melting agarose, NaCl, 
NaOH, Tris base, 5,5-dimethylpyrroline-N-oxide, ethidium 
bromide, and TRI reagent were purchased from Sigma-
Aldrich Chemie (Taufkirchen, Germany).
In vitro experiments
Fenton reaction – ESR measurements
Trapping of the hydroxyl radical was performed by 
5,5-dimethylpyrroline-N-oxide (DMPO)-spin trap. EPR 
spectra of the spin trap and radical complex were recorded 
at room temperature using a Bruker D-200 ER spectrometer 
(IBM Bruker Ltd, Coventry, UK), operating at X-band with 
a TM cavity and capillary tube. For the Fenton reaction 
(Fe2+ + H2O2 → Fe
3+ + OH + OH−), reactants containing 
80 mmol L-1 DMPO, 250 μmol L-1 ferrous sulphate, 
250 μmol L-1 H2O2 and 20 μL of 1,4-DHP were mixed in a 
test tube to a final volume of 100 μL and the reaction mixture 
was then transferred to a capillary tube for the measurement 
of the EPR signal. The EPR spectrometer settings were as 
follows: modulation frequency – 100 kHz; X band 
microwave frequency - 9.5 GHz; microwave power 
0–15 mW (milliwatts); modulation amplitude - 1.0 G 
(gauss); time constant – 160 s; scan time – 200 s, and 
receiver gain – 1 × l05 (15).
UV/VIS spectroscopic measurements and fluorescence 
assays
UV-VIS spectra of the tested compounds were recorded 
on a Perkin Elmer Lambda 25 UV/VIS spectrophotometer 
in the absence of DNA and presence of increasing amounts 
of DNA in 5 mmol L-1 NaCl and 5 mmol L-1 Tris HCl at pH 
7. The solution of the tested compound (25 μmol L-1) was 
diluted out of 1 mmol L-1 stock solution in the buffer in a 
quartz cell (1 mL). The reference cell was filled with 1 mL 
of buffer. The mixture was mixed thoroughly and titrated 
with 7.48 mmol L-1 of sonicated pTZ57R plasmid DNA 
solution, 5 μL each time to both sample and reference cells. 
Spectra were recorded in 400-200 nm interval at room 
temperature (10). Spectrofluorimetric analyses were 
performed on a Fluoromax-3 (Horiba JOBIN YVON, 
Edison, NJ, USA) device. The fluorescence spectra of 
25 μmol L-1 solution of compounds in 50 mmol L-1 NaCl 
and 5 mmol L-1 Tris HCl at pH 7 were recorded in the range 
of 365-600 nm at excitation wavelength of 350 nm or 
360 nm. DNA concentration was increased by 12.5 µmol 
at each step until saturation was obtained in fluorescence 
spectroscopic experiments on ethidium bromide extrusion 
from complex with DNA. The complex of plasmid DNA 
(74.8 μmol L-1) and ethidium bromide (1.26 μmol L-1) was 
titrated with 8.3 μmol L-1 aliquots of 2.5 mmol L-1 solution 
of the compound. Measurements were carried out at room 
temperature in 50 mmol L-1 NaCl and 5 mmol L-1 Tris HCl 
at pH 7 using 1 cm cuvette. Excitation wavelength was 
335 nm, fluorescence was measured at 600 nm. Binding 
constants were calculated as described (10, 12).
In vivo experiments
Animals
This study was approved by the Animal Ethics 
Committee of the Food and Veterinary Service (Riga, 
Latvia) and it was carried out according to the guidelines 
of the Directive 86/609/EEC “European Convention for the 
Protection of Vertebrate Animals Used for Experimental 
and other Scientific Purposes” (1986). Wistar male rats 
(215.0±5.6 g) were purchased from the Laboratory of 
Experimental Animals, Riga Stradins University, Riga, 
Latvia. Animals were kept at a temperature of 22±0.5 °C 
with a 12-h light/dark cycle and fed with a standard 
laboratory diet.
Experiment design
In total, 128 rats were used in the study. T1DM was 
induced by STZ injection via the tail vein (50 mg kg-1, 
freshly dissolved in 10 mmol L-1 citrate buffer, pH 4.5, 
injection volume 0.2-0.25 mL). Control rats received 
0.2 mL of 0.9 % NaCl via the tail vein. Diabetes was 
certified by measuring glucose level in tail vein blood of 
the fed rats in the morning 48 hours after the induction using 
a portative glucometer MediSense OptiumXceed (Abbott 
Diagnostics Ltd, Maidenhead, UK). Animals with blood 
glucose >13.89 mmol L-1 (250 mg dL-1) were used in 
experiments. The experiment was performed at day nine 
after confirmation of DM. Rats were divided in two big 
groups: control group (animals without DM) and STZ group 
(animals with induced DM). Each group was divided in 
seven subgroups: animals with no treatment, animals treated 
with either metcarbatone at low dose (0.05 mg kg-1 p.o. of 
metcarbatone for three days), metcarbatone at high dose 
(0.5 mg kg-1, similarly), etcarabtone at low dose, etcarbatone 
at high dose, styrylcarbatone at low dose or styrylcarbatone 
at high dose. Each group contained at least three animals. 
After the treatment course glucose was measured, then the 
rats were euthanised, kidney and blood samples of all 
animals were taken and frozen in liquid nitrogen for RNA 
extraction. Samples of heart, kidneys, eyes and sciatic nerve 
of animals in groups of untreated animals and animals 
treated with metcarbatone and etcarbatone were fixed for 
immunochemistry.
Tissue processing and immunohistochemical examination
Rat kidney, heart, eye and sciatic nerve tissue specimens 
were processed and examined essentially as described (10). 
Tissue specimens were fixed in 10 % neutral buffered 
formalin and embedded in paraffin. Specimens were cut in 
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5 µm thick section on a rotary microtome and mounted on 
poly-lysine coated glass slide. The following antibodies 
were used: rabbit polyclonal eNOS antibody (AbCam, 
Cambridge, UK, ab 66127; dilution 1:100), rabbit 
polyclonal iNOS antibody (AbCam, ab 3523; dilution 
1:200), anti-cleaved PARP1 rabbit monoclonal antibody 
(AbCam, ab32651, dilution 1:200), and rabbit polyclonal 
histone gamma-H2AX antibody (AbCam, ab11175, dilution 
1:500). Bound antibodies were detected using the EnVision 
(DAKO, Glostrup, Denmark) reagent (30 min at room 
temperature). The immunoperoxidase reaction colour was 
developed by incubating the slides with diaminobenzidine 
for 7 min. Each experiment included a negative control 
(mice tissues) omitting the primary antibody and positive 
controls (human tissues) - lung tissue and liver tissues for 
iNOS, liver and aorta tissues for eNOS and thyroid papillary 
carcinoma tissue for cleaved PARP1 and histone H2AX.
Gene expression studies
Gene expression studies were performed as described 
(10). Total RNA was isolated from kidneys and blood using 
TRI reagent and purified using DNA-free kit (Ambion, 
Austin, TX, USA). RNA quantity and purity were 
determined by spectrophotometry. The integrity of RNAs 
was monitored by gel electrophoresis and only specimens 
with well-pronounced rRNA bands were taken for reactions. 
To obtain cDNA, 2 μg of RNA were reverse-transcribed 
using a random hexamer primer (RevertAid™ First Strand 
Synthesis Kit, Fermentas, Vilnius, Lithuania) (10). Primer 
s e q u e n c e s  f o r  i N o s  g e n e  w e r e 
5’-GCTACACTTCCAACGCAACA-3’ (forward primer) 
and 5’-CATGGTGAACACGTTCTTGG-3’ (reverse 
p r i m e r ) .  P r i m e r s  f o r  e N o s  g e n e  w e r e 
5’-GAACCTGAGGGTGCCCAG-3’ (forward primer) and 
5’-TCCGATTCAACAGTGTCTCCT-3’ (reverse primer). 
P r i m e r s  f o r  P a r p 1  g e n e  w e r e 
5’-CGGAGAGGCTTTACCGAGTG-3’ (forward primer) 
and 5’-GAACATGGGTGACTGCACCA-3’ (reverse 
p r i m e r ) .  P r i m e r s  f o r  H 2 a f x  g e n e  w e r e 
5’-CGGTTTGTCTCCTGGCGTTT-3’ (forward primer) 
and 5’-ACATCGTGTGCGAGGTAGAA-3’ (reverse 
primer). Primers for xanthine deoxygenase gene Xdh were 
5’-CGGACCCTGAAACAACACTT-3’ (forward primer) 
and 5’-CAAGCAGGCATTGACAGAAA-3’ (reverse 
p r i m e r ) .  R N A - p o l y m e r a s e  I I 
( 5 ’ - G C C A G A G T C T C C C AT G T G T T- 3 ’ a n d 
5’-GTCGGTGGGACTCTGTTTGT-3’, 135 bp) was chosen 
as a reference gene.
SYBR® Green PCR Master Mix (Applied Biosystems, 
Foster City, CA, USA) was used for determination of gene 
expression. Amplification and detection of specific products 
were performed on a StepOne™ Real-Time PCR System 
(Applied Biosystems, Foster City, CA, USA) using the 
following temperature-time profile: one cycle of 95 ºC for 
10 min, and 40 cycles of 95 ºC for 15 sec, 60 ºC for 1 min. 
To check the specificity of the amplification products, the 
dissociation curve mode was used (one cycle at 95 ºC for 
15 sec, 60 ºC for 1 min, and 95 ºC for 15 sec). 
The single cell gel electrophoresis (comet assay)
The comet assay was performed as described (11, 16) 
with minor modifications (17). Blood for the comet assay 
was taken from the tail vein into a plastic capillary with 
heparin (Microvette CB 300, Sarstedt, Germany). Next, 
10 µL of fresh heparinised blood were mixed with 120 µL 
of prewarmed (37 ºC) 1 % low-melting agarose, 100 µL of 
the mixture were placed on a microscope slide that had been 
pre-coated with 0.5 % normal melting-point agarose. The 
cell membranes were lysed by keeping the slides in a cold 
lysing solution (pH 10.0) that contained 2.5 mol L-1 NaCl, 
10 mmol L-1 Na2EDTA, 10 mmol L
-1 Tris, 1 % Triton-X 
100, 5 % DMSO (Sigma-Aldrich, Germany), for at least 
1 h. Subsequently, the slides were placed in a horizontal 
tank filled with fresh electrophoresis buffer (1 mmol L-1 
Na2EDTA, 300 mmol L
-1 NaOH, pH 13.2) for 20 min to 
allow DNA to unwind. Then, horizontal electrophoresis 
was carried out for 20 min at 300 mA, 1 V cm-1 and 4 °C. 
After electrophoresis, slides were washed twice for 5 min 
with 0.4 mol L-1 Tris buffer (pH 7.5) for neutralisation and 
then fixed in ice-cold 96 % ethanol for 10 min. Slides were 
dried and stained with ethidium bromide and analysed with 
a fluorescence microscope equipped with 515–560 nm 
excitation filter and 590 nm barrier filter. Cells were visually 
graded into five classes (A0–A4) (11) from class 0 
(undamaged, no discernible tail) to class 4 (almost all DNA 
in tail, insignificant head). The mean value of DNA damage 
(D) in arbitrary units was calculated as follows: 
D=A1+2×A2+3×A3+4×A4.
Statistics
GraphPad Prism 6 software (San Diego, CA, USA) 
was used for statistical analysis. Results of the 
immunohistochemical data, real time PCR, and comet assay 
were analysed by an unpaired t test with Welch’s correction 
and two-way ANOVA followed by Dunnett’s multiple 
comparisons test. Data are presented as means±SEM.
RESULTS
Radical scavenging - EPR measurements
The ability of the 1,4-DHPs to scavenge the OH radical 
produced in the Fenton reaction was tested by the ESR 
method. The signals of the second compound of EPR spectra 
were measured on the 3rd (I3) and 5
th min (I5) and the 
difference between them I3 - I5 was calculated (Fig. 1; A). 
The scavengers of OH radicals should increase the 
difference between I3 and I5.  Representative kinetics of the 
decrease in the EPR signal intensity is shown in Figure 1B. 
Compounds were given at 1 mmol L-1 concentration. 
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Carbatone did not scavenge the hydroxyl radical produced 
in the Fenton reaction, metcarbatone was an effective 
scavenger (radical concentration decreased up to 31.4 % 
compared to the control, DMPO alone). Etcarbatone was 
less effective (up to 98.3 %); efficiency of propcarbatone 
was better than that of etcarbatone (86.4 %), but worse 
compared to metcarbatone. The scavenging efficiency of 
metcarbatone was dependent on the concentration: 
0.5 mmol L-1 decreased the radical concentration up to 
84.4 % of the radical; when given at concentrations 0.2 or 
0.1 mmol L-1 the compound was not effective (not shown). 
Styrylcarbatone even favoured the radicals’ generation up 
to 106 %.
DNA binding
The UV/VIS spectra of carbatone and propcarbatone 
are given in Figure 2, panel A. Other spectra are not shown. 
All the carbatonides absorbed light in the UV part of 
spectrum with a maximum at 235 nm and in the visible part 
of spectrum with a maximum at 380 nm for carbatone and 
at 355 nm for other carbatonides. In the UV/VIS titration 
assay carbatone, metcarbatone, etcarbatone, and 
propcarbatone manifested a slight hypochromic effect when 
interacting with DNA. Binding constants were 1.09 x 102 
for carbatone, 0.82x102 for metcarbatone, 0.54x102 for 
etcarbatone, and 1.11x102 for propcarbatone. Unlike other 
carbatonides, styrylcarbatone manifested a hyperchromic 
effect in the presence of DNA (not shown), its affinity to 
DNA was higher compared to other carbatonides 
(K=1.9x103 L mol-1). When irradiated with excitation light 
at 360 nm, all five compounds emitted fluorescence with a 
maximum at 450 nm. Interestingly, in the presence of DNA, 
fluorescence of carbatone and propcarbatone (not shown) 
was increased; on the contrary, DNA quenched fluorescence 
of metcarbatone (not shown), etcarbatone and styrylcarbatone 
(Stern-Volmer quenching constants were 3.8x102 L mol-1, 
9.5 x102 L mol-1 and 1.4x104 L mol-1, respectively; Figure 
2, panel B). Styrylcarbatone intercalates the DNA molecule 
as it effectively decreased fluorescence of 74.8 µmol L-1 
DNA and 1.26 µmol L-1 ethidium bromide complex - up to 
70 % after 16 additions of 10 µmol L-1 of the compound to 
the complex (Figure 2, panel C).
Figure 1 A - EPR spectra of DMPO-OH radicals generated in 
the Fenton reaction in presence of DMPO. 1 - EPR spectra of 
DMPO-OH radicals 3 min after mixing the components for the 
Fenton reaction. 2 - EPR spectra of DMPO-OH radicals 5 min 
after mixing the components for the Fenton reaction. I3 and I5 - 
intensities of EPR signals used for the quantification of DMPO-OH 
radicals in the corresponding time. 3 – difference between 3 min 
and 5 min spectra indicating a decrease in the signal intensity 
and lack of generation of other radicals. B – time of decrease in 
the intensity of DMPO-OH radical spectra, percent compared to 
the initial point
Figure 2 DNA binding of assays. (Panel A) UV/VIS spectroscopy. 
Plasmid DNA solution, 10 µmol L-1 each time, was added to both 
sample and reference cells. (Panel B) Fluorescence spectra of 
carbatonides with excitation at λ=360 nm (etcarbatone) and 
λ=350 nm (styrylcarbatone) in absence and presence of different 
concentrations of sonicated pTZ57R plasmid DNA. Carbatonide 
concentration was 25 µmol L-1, DNA concentration was increased 
by 12.5 µmol L-1 at each step until saturation. (Panel C) 
Fluorescence quenching plot of the ethidium bromide-pTZ57R 
plasmid DNA complex as a function of styrylcarbatone 
concentration
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the number of cells positive for this apoptotic protein 
following DM development was normalised by etcarbatone 
at both doses (P<0.001); metcarbatone did not produce any 
impact on the number of apoptotic cells. In eye tissues, 
there was also a three-fold increase (P=0.005) of c-PARP1 
positive cells after induction of diabetes; both doses of 
etcarbatone increased it even more (P<0.001) but 
metcarbatone showed no effect (Table 3).
Histone H2AX and H2afx gene
Numerical data are presented in Tables 2 and 3, 
microphotographs – in Figure 3. In kidneys, expression of 
H2AX was observed in proximal and distal canaliculi, in 
glomeruli, and blood vessel walls (Figure 3). The expression 
of this marker of DNA breakage on gene level did not 
Gene and protein expression studies
Styrylcarbatone, metcarbatone, and etcarbatone were 
chosen for the in vivo studies. These compounds did not 
produce the hypoglycaemic effect (not shown). The impact 
of these compounds on the expression of several genes and 
proteins involved in NO production and DNA repair were 
tested in the kidneys of normal and diabetic animals. The 
expression of genes was also monitored in blood samples. 
Besides kidneys, immunohistochemical studies were 
performed also on heart, nerve, and eye tissues.
The expression of the Parp1 gene (a marker of DNA 
repair), cleaved PARP1 protein (a marker of apoptosis), 
both proteins and genes of histone H2AX (DNA breakage 
marker) and two NO synthases (iNOS and eNOS) as well 
as Xdh gene (NO producing enzyme), were monitored. The 
quantified data of immunohistochemistry and real time PCR 
for kidneys are given in Tables 2-5.
Parp1 gene
We could not detect any significant differences in Parp1 
gene expression in kidneys of intact rats and animals with 
STZ diabetes mellitus (Table 2). However, the administration 
of styrylcarbatone, etcarbatone, and metcarbatone at both 
doses caused a highly significant more than two-fold 
increase (P<0.001) of the Parp1 gene expression in kidneys 
of intact animals. When administered to diabetic animals, 
all the three compounds, except etcarbatone at high dose, 
also caused a strong increase in the gene expression 
(P<0.01).
In blood cells, diabetes induction was followed by a 
strong, almost two-fold, increase in Parp1 gene expression 
(P=0.003). Both doses of etcarbatone attenuated the 
increase (P<0.001). However, styrylcarbatone and 
metcarbatone were not effective (Table 2).
Cleaved PARP1 (c-PARP1) protein
Development of the STZ-induced diabetes mellitus 
significantly increased the number of cells positive for 
c-PARP1 protein, a marker of apoptosis, in kidney tissue 
(P=0.004). Metcarbatone did not modify the expression of 
the enzyme in diabetic kidneys, while administration of 
etcarbatone at both doses decreased the number of cells 
positive for c-PARP1 in diabetic kidneys (P<0.001), 
although the compound upregulated the expression of the 
protein in kidneys of intact animals (P<0.05) (Table 3).
In heart  t issues,  c-PARP1 was detected in 
cardiomyocytes, in some inflammatory interstitial cells, and 
around blood vessels (Figure 3). Development of diabetes 
mellitus caused a three-fold increase in the cells positive 
for c-PARP1 protein in myocardium (P=0.025). The number 
of apoptotic cells was normalised by etcarbatone at both 
doses (P<0.01) and low dose of metcarbatone (P=0.018). 
In the sciatic nerve, the c-PARP1 protein was noticed in 
Schwann’s cells and in the inflammatory cells around nerve 
sheaths (not shown). The three-fold increase (P=0.009) in 
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Figure 3 Tissue distribution of apoptosis and DNA breakage 
markers. Upper panel: c-PARP1 expression in the myocardium. 
Immunohistochemical staining method, magnification × 200. A - 
control, B - etcarbatone at 0.05 mg kg-1, C - STZ (streptozotocin), 
D - STZ+etcarbatone at 0.05 mg kg-1. Arrow indicates positively 
stained cells. Lower panel: H2AX expression in the kidney tissue. 
Immunohistochemical staining method, magnification × 200. A - 
control, B - etcarbatone at 0.05 mg kg-1, C - STZ, D - STZ+etcarbatone 
at 0.05 mg kg-1. Arrow indicates positively stained cells
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change in the kidneys of animals in any group, however, 
etcarbatone treatment at both doses up-regulated protein 
expression in diabetic animals (P<0.01, Table 3). In diabetic 
animals, gene expression increased in blood (P=0.002); 
etcarbatone at both doses normalised this parameter 
(P<0.05); effects of styrylcarbatone and metcarbatone were 
not significant (Table 2). In the heart, the expression of 
histone was observed mostly in the nuclei of cardiomyocytes, 
to a lesser extent it was also seen in the nuclei of interstitial 
inflammatory cells and endocardium (not shown). 
Development of DM increased the number of histone H2AX 
positive cells in triplicate (P=0.005). Treatment with 
etcarbatone at both doses enhanced this increase (P<0.001). 
Metcarbatone at high dose decreased (P=0.038) the 
expression of H2AX in the nerve of intact rats but no other 
difference between the groups was observed in nerve and 
eye tissues (Table 3).
iNOS (NOS2) enzyme and iNos (Nos2) gene
Numerical data are presented in Tables 4 and 5. In 
kidneys, iNOS protein was expressed in glomeruli, 
canaliculi, stroma, and endothelium of blood vessels (not 
shown). Induction of diabetes caused a four-fold increase 
in the number of iNOS-positive cells (P=0.002), etcarbatone 
at low dose significantly decreased the expression (P=0.001) 
(Table 5), metcarbatone at low dose caused further up-
regulation (P<0.001). Strikingly, the effects of the 
compounds on gene expression level in kidneys were 
adverse (Table 4): the development of diabetes produced a 
less drastic increase in the intensity of gene transcription 
(P=0.044), etcarbatone at both doses produced an increase 
in intact animals (P<0.01), and at low dose it increased 
(P=0.003) the rate of transcription triggered by DM 
development. A similar effect was produced by metcarbatone 
at both doses (P<0.001). An even stronger increase in gene 
transcription was observed in blood cells (P=0.001), 
however, etcarbatone at both doses (P=0.003) and 
metcarbatone at low dose (P=0.01) attenuated the effect of 
DM but styrylcarbatone did not produce any effect. 
Immunohistochemical analysis of heart tissues revealed the 
expression of iNOS in cardiomyocytes, inflammatory cells, 
blood vessel walls, and stroma. The enzyme was detected 
in pericardium and endocardium but predominant 
expression was observed in myocardium (not shown). In 
DM model, the enzyme expression increased four-fold 
compared to the control group (P=0.003; Table 5). A 
significant decrease in the effect was produced only by 
etcarbatone at low dose (P=0.007). In the nerve, iNOS 









Control 0.68 ± 0.05 n=11
0.20 ± 0.02 
n=11
0.055 ± 0.007 
n=10
0.034 ± 0.006 
n=12
STZ 0.63 ± 0.04 n=9
0.21 ± 0.02 
n=11
0.089 ± 0.010 
n=15*
0.056 ± 0.007 
n=15*
Metcarbatone 0.05 mg kg-1 1.27 ± 0.19 n=4***
0.19 ± 0.02 
n=4
0.032 ± 0.009 
n=4
0.027 ± 0.006 
n=4
Metcarbatone 0.5 mg kg-1 1.19 ± 0.05 n=4***
0.21 ± 0.02 
n=4
0.023 ± 0.002 
n=4
0.019 ± 0.001 
n=4
Metcarbatone 0.05 mg kg-1 
+ STZ




0.093 ± 0.022 
n=4
0.041 ± 0.006 
n=4
Metcarbatone 0.5 mg kg-1 
+ STZ
1.55 ± 0.16 
n=5###
0.25 ± 0.01 
n=5




Etcarbatone 0.05 mg kg-1 1.67 ± 0.28 n=3***
0.24 ± 0.04 
n=3
0.023 ± 0.004 
n=3
0.021 ± 0.001 
n=3
Etcarbatone 0.5 mg kg-1 1.59 ± 0.07 n=4***
0.20 ± 0.02 
n=4




Etcarbatone 0.05 mg kg-1 
+ STZ
0.99 ± 0.08 
n=5##
0.24 ± 0.03 
n=5
0.036 ± 0.009 
n=5##
0.034 ± 0.006 
n=5#
Etcarbatone 0.5 mg kg-1 + 
STZ
0.85 ± 0.10 
n=5
0.18 ± 0.02 
n=5
0.033 ± 0.004 
n=5###




1.45 ± 0.16 
n=4***
0.24 ± 0.02 
n=4
0.062 ± 0.017 
n=4




1.72 ± 0.39 
n=4***
0.28 ± 0.09 
n=4
0.055 ± 0.010 
n=3
0.037 ± 0.008 
n=3
Styrylcarbatone  
0.05 mg kg-1 + STZ
1.53± 0.18 
n=5###
0.18 ± 0.02 
n=5
0.069 ± 0.013 
n=5
0.034 ± 0.006 
n=5
Styrylcarbatone  
0.5 mg kg-1 + STZ
2.37 ± 0.11 
n=5###
0.28 ± 0.02 
n=5
0.110 ± 0.022 
n=4
0.049 ± 0.009 
n=4
STZ – streptozotocin. Values are represented as the mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 vs. Control. #p<0.05; ##p<0.01; 
###p<0.001 vs. STZ
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expression was observed in Schwann’s cells (Figure 4); it 
increased in diabetic rats (P=0.003). A low dose of etcarbatone 
increased the expression in control rats (P<0.001), while both 
doses of etcarbatone decreased it in diabetic animals (P<0.05). 
Development of DM caused qualitative changes in the 
distribution of iNOS-positive cells in eye tissues: in the eyes 
of intact animals the expression was detected mostly in the 
ciliary body, while in diabetic animals iNOS positive cells 
were observed also in the retina and vitreous body. The general 
number of positive cells also increased (Figure 4). Quantitatively, 
induction of diabetes increased iNOS expression (P=0.021) 
but the compounds did not modify the expression significantly 
(Table 5).
eNOS (NOS3) enzyme and eNos (Nos3) gene
Data are presented in Tables 4 and 5. In heart tissues, 
eNOS expression was observed in the cytoplasm of 
cardiomyocytes and inflammatory cells and in endothelium 
(not shown). We could not detect significant differences 
between control and STZ group, however, etcarbatone 
treatment at both doses up-regulated the protein expression 
in the heart of diabetic animals (P<0.001). In kidney tissues, 
the enzyme was expressed in the cytoplasm of the cells 
forming proximal and distal canaliculi and in endothelium 
(not shown). Development of diabetes mellitus decreased 
the enzyme expression in kidneys compared to controls 
(P<0.001). The expression was up-regulated by a low dose 
of metcarbatone (P=0.016) and both doses of etacarbatone 
(P<0.001, Table 5). In nerve cells, eNOS protein expression 
increased by induction of diabetes (P=0.008). It was 
normalised by both doses of etcarbatone (P<0.01). In the 
eyes of intact animals, the expression of eNOS was 
restricted to the ciliar body; on the contrary, in diabetic 
animals it was observed not only in the ciliar body, but also 
in the retina, vitreous body, and inflammatory cells (not 
shown). Qualitative expansion of the expression was 
followed also by a numerical increase in eNOS-positive 
cells (P<0.001).
The expression of eNos gene decreased in the kidneys 
of diabetic animals (P=0.04, Table 4). Both etcarbatone and 
metcarbatone at high doses increased the expression levels 
(P=0.009 and P=0.024, respectively). Styrylcarbatone 
decreased gene expression by high dose in intact animals 
(P=0.019) and by low dose in diabetic rats (P=0.024).
Xanthine deoxygenase gene (Xdh)
Formerly we have demonstrated that the overall increase 
in NO production in STZ model of DM was due in part to 
NOS-independent production of NO by xanthine 
deoxygenase (10). Therefore, it was interesting to monitor 
the expression of this gene. Surprisingly, the increase in 
gene expression was detected only in the blood of diabetic 
animals (P=0.006; Table 4); styrylcarbatone and etcarbatone 
decreased it significantly (styrylcarbatone: P=0.02 for low 
dose; etcarbatone: P=0.003 for low dose, and P=0.001 for 
high dose). In kidneys, diabetes development did not change 
the expression of the gene, however, metcarbatone and 
styrylcarbatone up-regulated its expression in the kidneys 
of both control (metcarbatone: P=0.04 for low dose, 
P=0.003 for high dose; styrylcarbatone: P<0.001 for both 
doses) and diabetic animals (metcarbatone: P<0.001 for 
both doses, styrylcarbatone: P<0.001 for high dose). 
Etcarbatone produced similar effects; in the control group, 
it increased the expression of Xdh gene in the kidneys 
(P<0.001 for both doses). In diabetic animals, both 
concentrations of etcarbatone up-regulated gene expression 
(P=0.001 for low dose and P=0.015 for high dose).
Comet assay
Development of diabetes mellitus increased the level 
of DNA breakage in white blood cells (P<0.001, Figure 5). 
Surprisingly, metcarbatone, etcarbatone, and styrylcarbatone 
Figure 4 Tissue distribution of iNOS in organs of normal and 
diabetic rats. Upper panel: iNOS expression in the sciatic nerve 
tissue. Immunohistochemical staining method, magnification × 
200. A - control, B - etcarbatone at 0.5 mg kg-1, C - STZ 
(streptozotocin), D - STZ+etcarbatone 0.5 mg kg-1. Lower panel: 
iNOS expression in eye’s tissue. Immunohistochemical staining 
method, magnification × 200. A - control, B - etcarbatone at 
0.5 mg kg-1, C - STZ, D - STZ+etcarbatone at 0.5 mg kg-1








































































































































































































































































































































































































































































































































































































































































































































































































































































































































increased the level of DNA breakage in intact animals 
(P<0.05); etcarbatone at high dose drastically increased 
DNA lesions also in diabetic animals (P<0.001). However, 
metcarbatone at high dose (P<0.001) and styrylcarbatone 
at low dose (P=0.041) alleviated DNA damage level.
DISCUSSION
In the present study, we have performed in vitro and in 
vivo assays of several physicochemical properties and 
biological activities of carbatonides [disodium-2,6-
dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) 
derivatives]. Our aim was to evaluate a probable use of 
these compounds for treatinfg DM complications. It turned 
out that replacing groups in position 4 could drastically 
modify the hydroxyl radical scavenging capability of the 
compounds; metcarbatone was much more effective 
compared to other compounds. Indeed, former studies 
indicate that radical-scavenging activity is really determined 
by position 4; a free carboxylic group in this position is 
considered to be the most favourable for radical scavenging. 
Our study shows that methyl group in this position also 
favours effective scavenging, at least under conditions of 
the chosen assay. However, radical scavenging activity of 
1,4-DHPs strongly depends on the used system (4). Besides 
position 4, the tested compounds were identical, thus, the 
considerations that electron donor substituents in positions 
2 and 6 promote the quenching of oxidation, as well as 
stronger electron acceptors in positions 3 and 5 (4) cannot 
be applied to this study. All five compounds were capable 
of interacting with DNA, although their affinity to DNA 
was lower compared to other 1,4-DHPs (10, 12). The 
increase in fluorescence of carbatone and propcarbatone in 
the presence of DNA indicates a probable intercalation 
mechanism; the quenching of fluorescence by metcarbatone 
and etcarbatone indicates binding to the outer surface of 
DNA molecule (18). Interestingly, styrylacarbatone 
manifested a higher affinity to DNA, although DNA 
quenched its fluorescence, ethidium bromide extrusion 
assay indicates intercalation. The compound might interact 
with DNA via two mechanisms – intercalation and minor 
groove binding. Probably, direct interactions of 
styrylacarbatone, etcarbatone, and metcarbatone with DNA 
are responsible for DNA damage in white blood cells of the 
intact animals observed after the administration of these 
compounds. DNA-damaging effects of antioxidant 
compounds are a frequently observed phenomenon, for 
example, antioxidant flavonoids induce oxidative DNA 
damage serving as temporary carriers of electrons received 
from transition metal ions that are relayed to oxygen 
molecules to subsequently generate superoxide and H2O2 
(19). The DNA break reducing effect of metcarbatone in 
diabetic animals appears to be due to the radical scavenging 
activity of the compound, the weak scavenger etcarbatone 
even worsens the situation. This might be the cause of the 
increase in Parp1 gene expression in intact animals as a 
consequence of a triggered DNA repair process.
The gene and protein expression studies revealed several 
effects of these compounds, which appear to be benevolent 
in condition of diabetes mellitus. Coherent up-regulation 
of both mRNA and protein of eNOS in the kidneys of 
diabetic animals triggered by both metcarbatone and 
etcarbatone appears to be a promising effect. In the 
myocardium, the decrease in the eNOS protein expression 
was not pronounced, still etcarbatone up-regulated it in 
diabetic animals. The uncoupling of the endothelial NO 
synthase with consequent production of superoxide radical 
and decrease in NO bioavailability is an important factor 
in the pathogenesis of complications of DM (20). To heal 
the  compl ica t ions ,  the  uncoupl ing should  be 
pharmacologically reduced (21) but eNOS protein 
expression should be stimulated; its activity should be 
Figure 5 Effects of carbatonides on DNA integrity in white blood cells of normal and diabetic rats. STZ – streptozotocin; n=3-17. 
Values are represented as the mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 vs. Control. #p<0.05; ###p<0.001 vs. STZ
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increased (22, 23). Up-regulation of eNOS favours 
sensitivity to insulin (24). Recent data indicate an important 
role of the regulation of eNOS expression in many 
processes, despite its “constitutive” nature (25). Thus, 
metcarbatone and etcarbatone appear to produce favourable 
effects aimed at preventing diabetic nephropathy and 
cardiomyopathy. However, our results on the eNOS 
expression in eye tissues contradict the published data, as 
a decrease in eNOS in diabetic retina was observed by others 
(26). It seems that the problem should be studied more in 
detail. A similar effect was observed in the sciatic nerve, 
eNOS was up-regulated in diabetic animals, etcarbatone 
down-regulated its expression. Our data contradict the 
findings of others (27) indicating a decrease in eNos 
expression in the sciatic nerve of mice predisposed to 
development of DM and an increase in expression as a result 
of the applied therapy. However, our model of DM was 
different and nerve tissue might have its peculiarities. For 
example, a simultaneous increase in iNOS and eNOS was 
observed in the hippocampus of animals subjected to 
hypoxia (28). On the contrary, in the paraventricular nucleus 
of animals with modelled insulin resistance, eNOS was 
down-regulated; expression of iNOS did not change (29). 
Others have also shown an increased as well as decreased 
expression of eNOS in different tissues of diabetic animals 
(30).
The observed increase in iNOS protein and iNos gene 
in the studied tissues of diabetic animals was in good 
correlation with published data. The increase in iNOS 
expression coupled to DM was reported for cardiomyocytes 
(31), blood vessels (32), retina (26), sciatic nerve (27) and 
kidneys (10). The ability to decrease iNOS expression is 
considered to be a positive feature in the search for remedies 
which are aimed to treat diabetes complications (33). 
Etcarbatone appears to be prospective from this point of 
view, as it reduced the expression of iNOS protein in heart, 
nerve, and kidney tissues, metcarbatone was ineffective. 
Concerning iNos gene expression, it was drastically up-
regulated in the kidneys of intact animals by styrylcarbatone 
and etcarbatone, stronger than in the DM model, and also 
up-regulated by metcarbatone and etcarbatone in diabetic 
animals. In blood, the increase in the iNos gene expression 
was triggered by the development of DM, and etcarbatone 
and metcarbatone normalised it. Thus, the effects on iNOS 
protein and gene expression are not coherent. This can be 
explained by the mechanisms of gene regulation: it is 
regulated post-transcriptionally to a large extent, 
maintenance of mRNA stability being very important (34, 
35). The consequences of the observed outburst of mRNA 
expression could be levelled by post-transcriptional 
processing. Expression of the Parp1 gene related to DNA 
repair and induced by DNA breakage resembled to a large 
extent the pattern of the iNos gene expression, co-ordinate 
expression of these genes is due to common Nrf-2 pathway 
of their regulation (36, 37). Thus, 1,4-DHPs increased the 
expression of the gene in kidneys of both intact and diabetic 
animals. 1,4-DHPs per se did not increase gene expression 
in blood, but etcarbatone attenuated the DM-triggered 
increase. Interestingly, the effects on Xdh gene expression 
were similar; the enzyme contributes to a large extent to 
NOS-independent NO production. Surprisingly, these data 
are in contradiction with the level of DNA breakage – 
metcarbatone decreased it in diabetic animals but 
etcarbatone increased it. The marker of DNA double-strand 
breaks, the H2AX histone, did not react on DM induction 
in kidneys neither at gene, nor at protein expression levels. 
Surprisingly, etcarbatone up-regulated the expression of the 
protein, indicating the generation of double-strand DNA 
breaks. Discrepancy between mRNA and protein expression 
is not surprising, as the antibody detects the phosphorylated 
form of histone, generated after translation. It is 
phosphorylated by kinases such as ataxia telangiectasia 
mutated and ataxia telangiectasia mutated-Rad3-related in 
the PI3K pathway (38). However, we did observe an 
increased expression of the gene in blood cells, coherent 
with DNA breakage increase; perhaps, this reflects the fact 
that in lymphocytes the non-phosphorylated form of histone 
is also translocated to DNA breakage foci (39) triggering 
an increased transcription of the gene by feedback 
mechanism. Etcarbatone up-regulated also H2AX histone 
in myocardium. DNA double-strand breaks are usually 
associated with final stages of apoptosis; it was interesting 
to compare data on histone H2AX expression and 
generation of cleaved PARP1, a marker of apoptosis. In 
kidneys, DM triggered a sharp increase in the c-PARP1 
production; interestingly, etcarbatone treatment produced 
a strong anti-apoptotic effect. Thus, the DNA double-strand 
breaks produced by the compound should be repaired. The 
effects in myocardium were similar, again etcarbatone 
produced an anti-apoptotic effect, and thus H2AX 
expression indicates the generation of reparable double-
strand breaks formed prior to apoptosis. Action of 
etcarbatone in the sciatic nerve is also anti-apoptotic; 
unfortunately, it is pro-apoptotic in eye tissues.
Taken together, our data indicate that derivatives of 
disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-
bis(carbonyloxyacetate) appear to be a prospective 
compound group for the development of drugs aimed to 
treat DM complications like diabetic nephropathy, 
cardiomyopathy, and neuropathy. Etcarbatone appears to 
be the most prospective due to its ability to down-regulate 
iNOS, up-regulate eNOS, and prevent apoptosis in kidneys, 
hearts, and nerves of organisms suffering of hyperglycaemia.
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c-PARP1  cleaved poly [ADP-ribose] polymerase 1
D   DNA damage
DM   diabetes mellitus
DMPO   5,5-dimethylpyrroline-N-oxide
DMSO   dimethyl sulfoxide
EDTA   ethylenediaminetetraacetic acid
eNOS   endothelial nitric oxide synthase
EPR   electron paramagnetic resonance
ESR   electron spin resonance
G  gauss
H2afx  H2A histone family member X, gene
H2AX  H2A histone family member X, protein
iNOS   inducible nitric oxide synthase
mRNA   messenger RNA
NaCl  sodium chloride
NaOH  sodium hydroxide
NO   nitric oxide 
PARP1   poly [ADP-ribose] polymerase 1
PBS   phosphate-buffered saline
PCR   polymerase chain reaction
PI3K   phosphoinositide 3-kinase
p.o.   per os
SEM   standard error of the mean
STZ   streptozotocin
T1DM  type one diabetes mellitus 
UK   United Kingdom
USA   United States of America
UV/VIS   ultraviolet–visible
XDH   xanthine deoxygenase
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Modifikacije ekspresije gena i proteina koji su uključeni u popravak DNA i metabolizam dušikova oksida 
karbatonidima [derivati dinatrij-2,6-dimetil-1,4-dihidropiridin-3,5-bis(karboniloksiacetata)] u kontrolnih i 
dijabetičkih štakora
Rezultati ispitivanja patogeneze komplikacija šećerne bolesti (diabetes mellitus – DM) upozoravaju na to da bi tvari koje 
smanjuju nastanak slobodnih radikala a pospješuju popravak DNA mogle biti obećavajuće u budućem liječenju te bolesti. 
U ovome su istraživanju ispitana navedena svojstva karbatonida, derivata dinatrij-2,6-dimetil-1,4-dihidropiridin-3,5-
bis(karboniloksiacetata). EPR spektroskopija je pokazala da je metkarbaton učinkovit sakupljač hidroksilnih radikala koji 
nastaju Fentonovom reakcijom. Etkarbaton i propkarbaton su bili malo manje učinkoviti, a stirilkarbaton nije bio učinkovit. 
UV/VIS spektroskopija pokazala je hiperkromni učinak stirilkarbatona u interakciji s DNA, a svi ostali karbatonidi 
pokazali su hipokromni učinak. Štakori kod kojih je DM tipa 1 induciran streptozotocinom tretirani su metkarbatonom, 
etkarbatonom ili stirilkarbatonom (sve tvari su davane u dozi 0,05 mg kg-1 ili 0,5 mg kg-1) tijekom devet dana nakon što 
je potvrđeno da je izazvan DM. Razine ekspresije gena u bubrezima procijenjene su kvantitativnim RT-PCR-om, ekspresija 
proteina – imunohistokemijski u bubrezima, srcu, ishijadičnom živcu i očima, a lom DNA – komet-testom bijelim krvnim 
stanicama. Indukcija DM-a uzrokovala je lomove u DNA; metkarbaton i stirilkarbaton (niska doza) ublažili su ovaj učinak. 
Metkarbaton i etkarbaton pojačali su mRNA i ekspresiju proteina eNOS-a u bubrezima dijabetičkih životinja; etkarbaton 
je takav učinak pokazao i u miokardu. Etkarbaton je smanjio ekspresiju iNOS proteina u miokardu, živcu i bubrezima. 
Ekspresija iNOS-a bila je pojačana u bubrezima primjenom etkarbatona i metkarbatona u dijabetičkih životinja. Razvoj 
DM povećao je ekspresiju iNOS-a u krvi, a etkarbaton i metkarbaton vratili su ju na normalne vrijednosti. Etkarbaton je 
pojačao ekspresiju H2AX u bubrezima dijabetičkih životinja, ali je smanjio proizvodnju c-PARP1. Naši podaci upućuju 
na potencijal karbatonida kao lijekova za liječenje komplikacija uzrokovanih dijabetesom.
KLJUČNE RIJEČI: derivati 1,4-dihidropiridina; diabetes mellitus; DNA lom; sakupljači slobodnih radikala; sintaza 
dušikova oksida 
